Searched for
PHARMACEUTICAL PRODUCTS FROM INDIA
US exempts India and 19 nations from 100% tariff on certain speciality drugs: ReportThe United States has announced it will exempt certain speciality drugs and ingredients imported from India and 19 other countries from tar...- India’s healthcare AI opportunity could become the next big investment storyThe digital rails are ready. India now needs patient capital and founders ambitious enough to build on them.
- India electronics firms get Rs 19,091 crore PLI incentives, investments cross Rs 20,580 croreElectronics manufacturing companies have received substantial incentives under the production-linked incentive scheme and attracted signifi...
- Netflix cancels How to Get to Heaven from Belfast after it Hit No. 1: So what went wrong?Channel 4 first gave the project How to Get to Heaven from Belfast the green light in 2023. It later found a new home at Netflix as product...
- PLI scheme attracts Rs 2.40 lakh crore investments across 14 sectors, enhancing manufacturing capacity: ReportThe ASSOCHAM report indicates that the Production Linked Incentive Scheme has attracted significant investment across various sectors. It e...
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
- Deon Energy files draft papers with Sebi to raise funds via IPODeon Energy, an Ahmedabad-based solar EPC firm, is set to launch an IPO to gather capital. This offering will feature a fresh equity share ...
- Forced labour and import: Reading India’s latest foreign trade policy additionsWith this notification in place, India has tried to put a protective layer for the domestic industry from unfair foreign competition.
- India’s FDI equity inflows rise 6% to $19.8 billion in Q1FY27; Japan tops, US plunges 76%India’s FDI equity inflows rose 6% to $19.81 billion in April-June FY27, led by Japan at $5.7 billion, while US inflows fell 76% to $1.34 b...
- Govt disburses Rs 36,754 cr under PLI schemes as on June 30The government has disbursed Rs 36,754 crore to beneficiary companies under the Production Linked Incentive schemes. These schemes have led...
- India records highest-ever FDI of $94.53 billion in FY26, inflows since 2014 reach $843 billion: Piyush GoyalIndia achieved its highest-ever annual Foreign Direct Investment of USD 94.53 billion in FY 2025-26. Cumulative FDI inflows from FY 2014-15...
- Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 croreSanofi Healthcare India acquired a significant 15.2 percent stake in Sanofi India through an open market transaction. The company purchased...
- Jagsonpal Pharma to acquire Group Pharma’s wellness portfolioJagsonpal Pharmaceuticals has signed a business transfer agreement to acquire the wellness portfolio of Group Pharmaceuticals. The acquisit...
- Pharma sector revenue to grow 11-13 pc in FY27 on strong exports, domestic demand: CrisilIndia's pharmaceutical sector is projected to grow at 11-13 percent this fiscal year due to export increases. The domestic market is also e...
- Zydus Lifesciences expects decent growth for five years as innovation matures: Sharvil PatelZydus Lifesciences is transitioning from a traditional pharmaceutical company to a more patient-driven organization. The company plans to f...
- Private sector growth hits three-month highManufacturing PMI climbed to a seven-month high of 55.7 in September from 52.8 in August, while services activity increased to 55.8 from 54...
- Gautam Adani reclaims richest Indian spot from Mukesh Ambani as India's billionaire count hits record: HurunGautam Adani has overtaken Mukesh Ambani to reclaim the top spot on the M3M Hurun India Rich List 2026, with wealth of Rs 9.23 lakh crore. ...
- Gautam Adani reclaims top spot as India’s richest, edges out Mukesh Ambani: Hurun Rich ListGautam Adani has overtaken Mukesh Ambani to reclaim the top spot on the M3M Hurun India Rich List 2026, with wealth of Rs 9.23 lakh crore. ...
- Pfizer India speaks up after Karnataka FDA crackdown, says patient safety is top priorityPfizer India has stated that patient safety and product quality are their top priorities following FDA actions. The Karnataka FDA canceled ...
- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
Load More
